Inhibition of Activin Receptor Type IIB Increases Strength and Lifespan in Myotubularin-Deficient Mice

Michael W. Lawlor(Medical College of Wisconsin), Alan H. Beggs(Boston Children's Hospital), Jennifer Lachey(Acceleron Pharma (United States)), Nicole Yang(Brigham and Women's Hospital), Jasbir Seehra(Acceleron Pharma (United States)), Matthew J. Stein(Boston Children's Hospital), Christopher R. Pierson(Nationwide Children's Hospital), Anna Buj-Bello(Genethon (France)), Rachel Edelstein(Boston Children's Hospital), Benjamin Read(Boston Children's Hospital), Ariana Wermer-Colan(Boston Children's Hospital)
American Journal Of Pathology
January 29, 2011
Cited by 62


Related Papers